Steatohepatitis, Nonalcoholic Clinical Trials
2 recruiting trials for Steatohepatitis, Nonalcoholic. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Steatohepatitis, Nonalcoholic clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by National Taiwan University Hospital (1), Institute of Cancer Research, United Kingdom (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Hydrochloroquine (drug, 1 trial), followed by Placebo, Ultrasound image processing.
Track Steatohepatitis, Nonalcoholic trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis
The goal of this clinical trial is to learn if drug hydroxychloroquine works to treat steatohepatitis in adults. It will also learn about the safety of drug hydroxychloroquine....
The COherence of Scatter Identification and Exclusion Algorithm Study
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver condition worldwide; approximately 55% of the world population will have NAFLD by 2040. NAFLD is an...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Steatohepatitis, Nonalcoholic, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Steatohepatitis, Nonalcoholic, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Steatohepatitis, Nonalcoholic, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.